Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility.
about
Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and CImpact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapyHIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.Molecular mechanism of HIV-1 resistance to 3'-azido-2',3'-dideoxyguanosine.Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapyA376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
P2860
Q28484213-420703C4-F402-4DAF-948E-0681397ECF5BQ30395110-36D6A446-401E-430F-8C28-87A97326B88AQ35943486-813348FF-AB36-4264-AED7-BE52DEE1B0F7Q37470030-1EF7378A-85A4-4AD9-A2E8-0B5761F17B94Q39664167-95CC7DC8-7703-49C7-9712-B446DEEDC778Q42159090-1BA4C170-4773-4359-BAE0-ED665EFB6FC8Q42430831-25565C16-5C83-4AC6-B0CB-59309C602A7DQ54567693-670AA20E-C22C-45BF-B615-EECEB2A61499
P2860
Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of the human immunodefi ...... acity and drug susceptibility.
@en
Effect of the human immunodefi ...... acity and drug susceptibility.
@nl
type
label
Effect of the human immunodefi ...... acity and drug susceptibility.
@en
Effect of the human immunodefi ...... acity and drug susceptibility.
@nl
prefLabel
Effect of the human immunodefi ...... acity and drug susceptibility.
@en
Effect of the human immunodefi ...... acity and drug susceptibility.
@nl
P2093
P2860
P50
P356
P1433
P1476
Effect of the human immunodefi ...... pacity and drug susceptibility
@en
P2093
Anna Artese
Bonaventura Clotet
Francesca Ceccherini-Silberstein
P2860
P304
P356
10.1128/JVI.00487-09
P407
P50
P577
2009-05-20T00:00:00Z